Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,141 | -33,536 | -40,946 | -25,060 | -140,039 |
| Depreciation Amortization | 2,573 | 1,999 | 1,988 | 2,273 | -4,942 |
| Accounts receivable | -73,163 | -42,050 | -33,621 | -12,349 | -47,259 |
| Accounts payable and accrued liabilities | -1,694 | -8,425 | 863 | 309 | 2,229 |
| Other Working Capital | -34,829 | -32,503 | -12,559 | -17,687 | -15,080 |
| Other Operating Activity | 117,629 | 82,705 | 54,219 | 22,134 | 92,933 |
| Operating Cash Flow | $-5,625 | $-31,810 | $-30,056 | $-30,380 | $-112,158 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,567 | 14,612 | 39,859 | 12,358 | 33,963 |
| PPE Investments | -686 | -686 | -686 | -608 | -143 |
| Purchase Sale Intangibles | -10,000 | -10,000 | -10,000 | N/A | -5,000 |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | 0 | -5,000 |
| Investing Cash Flow | $-30,253 | $3,926 | $29,173 | $11,750 | $28,820 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -100,000 |
| Common Stock Issued | 6,973 | 3,251 | 1,775 | 395 | 166,202 |
| Financing Cash Flow | $6,973 | $3,251 | $1,775 | $395 | $66,202 |
| Exchange Rate Effect | 168 | 109 | 204 | 4 | -235 |
| Beginning Cash Position | 71,952 | 71,952 | 71,952 | 71,952 | 89,323 |
| End Cash Position | 43,215 | 47,428 | 73,048 | 53,721 | 71,952 |
| Net Cash Flow | $-28,737 | $-24,524 | $1,096 | $-18,231 | $-17,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,625 | -31,810 | -30,056 | -30,380 | -112,158 |
| Capital Expenditure | -686 | -686 | -686 | -608 | -143 |
| Free Cash Flow | -6,311 | -32,496 | -30,742 | -30,988 | -112,301 |